OverviewSuggest Edit

ICON is a company that provides outsourced clinical research and development services to the pharmaceutical, biotechnology, and medical device industries. It delivers preclinical and clinical research services, adaptive trials, biosimilar development, consulting, medical imaging, bioanalytical and central laboratories, full-spectrum resourcing, etc.
TypePublic
Founded1990
HQDublin 18, IE
Websiteiconplc.com
Employee Ratings3.7
Overall CultureF

Latest Updates

Employees (est.) (Jun 2020)15,150
Job Openings1,366
Revenue (FY, 2020)$2.8 B
Share Price (Jun 2021)$212.2(-2%)
Cybersecurity ratingBMore

Key People/Management at ICON

Arancha Lopez

Arancha Lopez

Senior Director in Project Management Read About
Steve Cutler

Steve Cutler

Chief Executive Officer & Director
Joe Cronin

Joe Cronin

Chief Human Resources Officer
Brendan Brennan

Brendan Brennan

Chief Financial Officer
George A. McMillan

George A. McMillan

Chief Commercial Officer
Tom O'Leary

Tom O'Leary

Chief Information Officer
Show more

ICON Office Locations

ICON has offices in Dublin 18, Boston, Brentwood, Cambridge and in 63 other locations
Dublin 18, IE (HQ)
Leopardstown Racecourse, Foxrock
Villa Adelina, AR
1st floor, Av. Fondo de la Legua 1171
Macquarie Park, AU
201/2-4 Lyonpark Rd
Wien, AT
Pyrkergasse 10
Sao Paulo, BR
Av. Ibirapuera, 2332 - 4o andar - Indianópolis
Burlington, CA
400-3455 N Service Rd
Show all (70)

ICON Financials and Metrics

ICON Revenue

Embed Graph
View revenue for all periods
ICON's revenue was reported to be $2.8 b in FY, 2020
USD

Revenue (FY, 2020)

2.8b

Gross profit (FY, 2020)

817.4m

Gross profit margin (FY, 2020), %

29.2%

Net income (FY, 2020)

333.0m

EBIT (FY, 2020)

391.5m

Market capitalization (18-Jun-2021)

11.2b

Closing stock price (18-Jun-2021)

212.2

Cash (31-Dec-2020)

840.3m

EV

10.8b
ICON's current market capitalization is $11.2 b.
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Revenue

1.8b2.6b2.8b2.8b

Revenue growth, %

48%8%

Cost of goods sold

1.0b1.8b2.0b2.0b

Gross profit

731.1m777.6m831.7m817.4m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

620.1m641.6m655.0m674.9m695.1m710.4m715.1m620.2m

Cost of goods sold

430.6m449.2m459.2m475.5m490.7m499.8m505.3m445.8m

Gross profit

189.5m192.4m195.8m199.4m204.5m210.7m209.8m174.4m

Gross profit Margin, %

31%30%30%30%29%30%29%28%
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Cash

282.9m395.9m520.3m840.3m

Accounts Receivable

379.5m414.8m527.7m715.3m

Prepaid Expenses

53.5m

Current Assets

1.1b1.3b1.6b2.1b
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

281.5m322.7m375.9m333.0m

Depreciation and Amortization

61.3m65.9m61.6m66.1m

Accounts Payable

7.0m(5.1m)3.4m26.5m

Cash From Operating Activities

383.1m268.6m412.5m568.0m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

78.1m150.0m234.5m88.3m180.5m276.0m92.3m140.1m

Depreciation and Amortization

16.9m33.9m51.0m15.5m30.7m45.8m16.3m32.2m

Accounts Payable

(6.7m)(3.2m)(3.0m)5.4m(16.7m)1.6m(897.0k)8.4m

Cash From Operating Activities

40.5m79.7m207.8m94.6m117.4m278.1m142.8m260.6m
USDFY, 2017

Revenue/Employee

132.7k

Debt/Equity

0.3 x

Debt/Assets

0.2 x

Financial Leverage

1.8 x
Show all financial metrics

ICON Operating Metrics

FY, 2017Q1, 2018Q2, 2018Q3, 2018FY, 2018Q1, 2019Q2, 2019Q3, 2019FY, 2019Q1, 2020Q2, 2020

Countries

3838373737374040404040
Show all operating metrics

ICON Acquisitions / Subsidiaries

Company NameDateDeal Size
Addplan, Inc.
Beacon Bioscience, Inc.
C4 MedSolutions, LLC
CHC Group, LLC
Clinical Resource Network, LLC
Complete Healthcare Communications, LLC
Complete Publication Solutions, LLC
CRN Holdings, LLC
CRN North America, LLC
DOCS Global, Inc.
Show more

ICON Revenue Breakdown

Embed Graph

ICON revenue breakdown by geographic segment: 44.7% from Ireland, 13.9% from Rest of Europe, 31.8% from United States of America and 9.7% from Other

ICON Cybersecurity Score

Cybersecurity ratingPremium dataset

B

84/100

SecurityScorecard logo

ICON Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

ICON Online and Social Media Presence

Embed Graph

ICON Company Culture

  • Overall Culture

    F

    34/100

  • CEO Rating

    F

    50/100

  • Compensation

    F

    10/100

Learn more on Comparably

ICON News and Updates

ICON Reports Second Quarter 2020 Results

ICONplc (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today reported its financial results for the second quarter ended June 30, 2020.

ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting

ICONplc (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations, today announced that all resolutions at the Annual General Meeting of the Company (AGM) …

ICON plc to Present at Jefferies Virtual Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the Jefferies Virtual Healthcare Conference on Tuesday,…

ICON plc to Present at UBS Virtual Global Healthcare Conference

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the UBS Virtual Global Healthcare Conference on Wedn…

ICON Appoints New Chief Medical Officer

ICON plc, (NASDAQ: ICLR) a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Kristen K. Buck has been appointed Chief Medical Officer.

ICON Reports First Quarter 2020 Results

Net business wins in the quarter of $867 million; a book to bill of 1.21. Record closing backlog of $8.7 billion, an increase of 10.4% year on year. Quarter 1 reported revenue of $715.1 million representing a 6.0% year on year increase or 6.5% on a constant currency basis.
Show more

ICON Frequently Asked Questions

  • When was ICON founded?

    ICON was founded in 1990.

  • Who are ICON key executives?

    ICON's key executives are Arancha Lopez, Steve Cutler and Joe Cronin.

  • How many employees does ICON have?

    ICON has 15,150 employees.

  • What is ICON revenue?

    Latest ICON annual revenue is $2.8 b.

  • What is ICON revenue per employee?

    Latest ICON revenue per employee is $184.6 k.

  • Who are ICON competitors?

    Competitors of ICON include Precision for Medicine, Syneos Health and PRA Health Sciences.

  • Where is ICON headquarters?

    ICON headquarters is located at Leopardstown Racecourse, Foxrock, Dublin 18.

  • Where are ICON offices?

    ICON has offices in Dublin 18, Boston, Brentwood, Cambridge and in 63 other locations.

  • How many offices does ICON have?

    ICON has 70 offices.